Investor Presentation January 2021
A research-driven innovation process.
Supported by unrivalled capabilities and innovation
> 69
Creation and
application
Centres
>>122,600
Products sold
per year
CHF 536 mln
R&D spend in
2020
Update figures
> 500
Employees in
Science &
Technology
> 3,600
Active
patents
Givaudan
-0000
Innovation initiatives and priorities
Supplier enabled
innovation
partnerships with
bioscience companies
Delivering differentiating
technologies and solutions in
Flavours, nutritional and
functional ingredients (clean
label delivery systems, health
and wellbeing solutions etc.)
Enabling novel consumer
experiences in Fragrances:
naturals, new sensory
experiences, sustainable
new molecules and
precursors etc.
Investor presentation January 2021
9View entire presentation